The Indigenous Archives Collective position statement on the right of reply to Indigenous knowledges and information held in archives

2021 ◽  
pp. 1-9
Author(s):  
Indigenous Archives Collective
Keyword(s):  
Position Statement ◽  
Indigenous Knowledges ◽  
Indigenous Archives ◽  
The Right

Reflecting on the Education Position Statement of AAIDD and The Arc

Inclusion ◽  
2020 ◽  
Vol 8 (1) ◽  
pp. 6-26
Author(s):  
Anthony M. Rodriguez ◽  
Debbie Taub ◽  
LaRon Scott ◽  
Susan R. Copeland ◽  
Kendra Williams-Diehm ◽  
...  
Keyword(s):  
Developmental Disabilities ◽  
School Choice ◽  
Postsecondary Education ◽  
Position Statement ◽  
System Capacity ◽  
Educational Systems ◽  
Intellectual And Developmental Disabilities ◽  
High Expectations ◽  
Research Findings ◽  
The Right

Abstract This article expands on 10 critical actions within the American Association on Intellectual and Developmental Disabilities (AAIDD) and The Arc's 2018 joint position statement on the right of students with intellectual and developmental disabilities (IDD) to have a free and appropriate public education (FAPE): (a) zero reject; (b) nondiscriminatory and comprehensive eligibility evaluations and appropriate assessments; (c) high expectations and FAPE; (d) autonomy, self-determination, and decision-making supports; (e) inclusion and least restrictive environments (LRE); (f) safe and supportive education environments; (g) school choice; (h) family and student participation; (i) lifelong education, transition, and postsecondary education; and (j) system capacity development, funding, oversight, and accountability. Research findings documenting positive outcomes associated with implementing each area of action are described and relevant legal mandates and case law are discussed. Recommendations are made for changes to educational systems and practices that create barriers to the access of FAPE for students with IDD.

scholarly journals Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders

2021 ◽  
Vol 5 (2) ◽  
pp. 14
Author(s):  
Giovanni Frisoni ◽  
Jean-Marie Annoni ◽  
Stefanie Becker ◽  
Tim Brockmann ◽  
Markus Buerge ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Health Care ◽  
Early Diagnosis ◽  
Old Age ◽  
State Of The Art ◽  
Position Statement ◽  
Swiss Health ◽  
The Right ◽  
To Receive

The present document represents the position of Swiss health-care associations, clinical and research centers, research-supporting foundations, and the association Alzheimer Switzerland regarding the care of persons with dementia and Alzheimer’s disease. We claim that dementia is not part of normal aging but a disease developing more frequently in old age; early diagnosis and treatment of dementia is paramount; all patients with dementia have the right to receive state-of-the-art treatments; more intense information, education, and counseling on dementia are necessary; media should provide balanced and fair reporting of scientific discoveries on Alzheimer’s and dementia; all patients with dementia have the right to be treated; anti-dementia drugs should be used and accompanied by listening, compassion, and understanding.

Canadian neurosurgeons’ views on medical assistance in dying (MAID): a cross-sectional survey of Canadian Neurosurgical Society (CNSS) members

2019 ◽  
Vol 45 (5) ◽  
pp. 309-313 ◽  
Author(s):  
Alwalaa Althagafi ◽  
Chris Ekong ◽  
Brian W Wheelock ◽  
Richard Moulton ◽  
Peter Gorman ◽  
...  
Keyword(s):  
Position Statement ◽  
Conscientious Objection ◽  
Supreme Court Of Canada ◽  
Medical Assistance ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Medical Assistance In Dying ◽  
Neurosurgical Society ◽  
Views And Perceptions ◽  
The Right

BackgroundThe Supreme Court of Canada removed the prohibition on physicians assisting in patients dying on 6 February 2015. Bill C-14, legalising medical assistance in dying (MAID) in Canada, was subsequently passed by the House of Commons and the Senate on 17 June 2016. As this remains a divisive issue for physicians, the Canadian Neurosurgical Society (CNSS) has recently published a position statement on MAID.MethodsWe conducted a cross-sectional survey to understand the views and perceptions among CNSS members regarding MAID to inform its position statement on the issue. Data was collected from May to June 2016.ResultsOf the 300 active membes of the CNSS who recevied the survey, 89 respondents completed the survey, 71% of whom were attending neurosurgeons and 29% were neurosurgery residents. Most respondents,74.2%, supported the right of physicians to participate in MAID with 7.8% opposing. 37% had current patients in their practice fitting the criteria for MAID. 23.6% had been asked by patients to assist with MAID, but only 11% would consider personally providing it. 84% of neurosurgeons surveyed supported the physicians’ right to conscientious objection to MAID while 21% thought attending surgeons should be removed from the inquiry and decision-making process. 43.8% agreed that the requirment to refer a patient to a MAID service should be mandatory. Glioblastoma multiforme (65%), quadriplegia/quadriparesis secondary to spinal tumour/trauma (54%) and Parkinson’s disease (24%) were the most common suggested potential indications for MAID among the neurosurgical population.ConclusionsOur results demonstrate that most neurosurgeons in Canada are generally supportive of MAID in select patients. However, they also strongly support the physicians’ right to conscientious objection.

Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression

2012 ◽  
Vol 27 (2) ◽  
pp. 114-128 ◽  
Author(s):  
H.-J. Möller ◽  
I. Bitter ◽  
J. Bobes ◽  
K. Fountoulakis ◽  
C. Höschl ◽  
...  
Keyword(s):  
Drug Treatment ◽  
Clinical Decision Making ◽  
Psychiatric Treatment ◽  
Severe Depression ◽  
Position Statement ◽  
Therapeutic Drug ◽  
Number Needed To Treat ◽  
Evidence Based ◽  
Double Blind ◽  
The Right

AbstractThis position statement will address in an evidence-based approach some of the important issues and controversies of current drug treatment of depression such as the efficacy of antidepressants, their effect on suicidality and their place in a complex psychiatric treatment strategy including psychotherapy. The efficacy of antidepressants is clinically relevant. The highest effect size was demonstrated for severe depression. Based on responder rates and based on double-blind placebo-controlled studies, the number needed to treat (NNT) is 5–7 for acute treatment and four for maintenance treatment. Monotherapy with one drug is often not sufficient and has to be followed by other antidepressants or by comedication/augmentation therapy approaches. Generally, antidepressants reduce suicidality, but under special conditions like young age or personality disorder, they can also increase suicidality. However, under the conditions of good clinical practice, the risk–benefit relationship of treatment with antidepressants can be judged as favourable also in this respect. The capacity of psychiatrists to individualise and optimise treatment decisions in terms of ‘the right drug/treatment for the right patient’ is still restricted since currently there are no sufficient powerful clinical or biological predictors which could help to achieve this goal. There is hope that in future pharmacogenetics will contribute significantly to a personalised treatment. With regard to plasma concentration, therapeutic drug monitoring (TDM) is a useful tool to optimize plasma levels therapeutic outcome. The ideal that all steps of clinical decision-making can be based on the strict rules of evidence-based medicine is far away from reality. Clinical experience so far still has a great impact.

scholarly journals P.009 Physician assisted death and the neurosurgeon

2016 ◽  
Vol 43 (S2) ◽  
pp. S23-S23
Author(s):  
SP Barry ◽  
I Fleetwood ◽  
K Reddy ◽  
C Ekong ◽  
P Gorman ◽  
...  
Keyword(s):  
Health Care Providers ◽  
Position Statement ◽  
Criminal Code ◽  
Third Party ◽  
Care Providers ◽  
Assisted Death ◽  
Referral Service ◽  
Neurosurgical Society ◽  
The Creation ◽  
The Right

Background: The Supreme Court of Canada (SCC) recently rendered a decision striking down the Criminal Code absolute prohibition on providing assisted dying. End of life decisions are commonly encountered by neurosurgeons due to the nature of their practice. Neurosurgeons will be faced with patients requesting PAD in the near future. Methods: The recent SCC ruling heralds a change that will radically alter a most basic tenet that has historically guided physicians and surgeons. A subcommittee of the Canadian Neurosurgical Society (CNSS) was formed to generate a position statement to reflect the interests of both neurosurgeons and their patients. Results: Fundamental issues regarding the implementation of PAD identified include:Clarity of legislationThe creation of an independent, third party referral serviceEffective safeguards and oversight of the entire process-The right to “conscientious objection” on the part of hysicians who do not wish to be involved in PADConclusions: The CNSS urges clarity in legislation regarding PAD and strict oversight in its implementation to reduce potential harm. We also support the creation of an independent, third party referral service which would serve to respect the conscience of those health care providers who do not wish to actively participate in PAD.

Position Statement of the European Psychiatric Association (EPA) on the Value of Antidepressants in the Treatment of Unipolar Depression

2011 ◽  
Vol 26 (S2) ◽  
pp. 2200-2200
Author(s):  
H.-J. Möller
Keyword(s):  
Drug Treatment ◽  
Clinical Decision Making ◽  
Psychiatric Treatment ◽  
Severe Depression ◽  
Position Statement ◽  
Therapeutic Drug ◽  
Number Needed To Treat ◽  
Evidence Based ◽  
Double Blind ◽  
The Right

This position statement will address in an evidence-based approach some of the important issues and controversies of current drug treatment of depression such as the efficacy of antidepressants, their effect on suicidality, their place in a complex psychiatric treatment strategy including psychotherapy.The efficacy of antidepressants is clinically relevant. The highest effect size was demonstrated for severe depression. Based on responder rates and based on double-blind placebo-controlled studies, the number needed to treat (NNT) is 5–7 for acute treatment and 4 for maintenance treatment. Monotherapy with one drug is often not sufficient but has to be followed by other antidepressants or by comedication/augmentation therapy approaches.Generally antidepressants reduce suicidality, but under special conditions like young age or personality disorder, they can also increase suicidality. However, under the conditions of good clinical practice, the risk-benefit relationship of treatment with antidepressants can be judged as favourable also in this respect.The capacity of psychiatrists to individualise and optimise treatment decisions in terms of ‘the right drug/treatment for the right patient’ is still restricted since currently there are no sufficient powerful clinical or biological predictors which could help to achieve this goal. There is hope that in future pharmacogenetics will contribute significantly to a personalised treatment. With regard to plasma concentration, therapeutic drug monitoring (TDM) is a useful tool to optimize plasma levels therapeutic outcome.The ideal that all steps of clinical decision making can be based on evidence-based medicine is far away from reality. Clinical experience still has a great impact.

Investor-State Dispute Settlement under NAFTA Chapter 11: The Shape of Things to Come?

1998 ◽  
Vol 35 ◽  
pp. 263-290
Author(s):  
J. Anthony VanDuzer
Keyword(s):  
Free Trade Agreement ◽  
Dispute Settlement ◽  
Trade Agreement ◽  
Minimum Standards ◽  
The North ◽  
State Behaviour ◽  
Nafta Chapter 11 ◽  
To Come ◽  
The Right

SummaryRecently, there has been a proliferation of international agreements imposing minimum standards on states in respect of their treatment of foreign investors and allowing investors to initiate dispute settlement proceedings where a state violates these standards. Of greatest significance to Canada is Chapter 11 of the North American Free Trade Agreement, which provides both standards for state behaviour and the right to initiate binding arbitration. Since 1996, four cases have been brought under Chapter 11. This note describes the Chapter 11 process and suggests some of the issues that may arise as it is increasingly resorted to by investors.

Sign in / Sign up

Export Citation Format

Share Document